Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Current Leases (2022 - 2023)

Cullinan Therapeutics has reported Current Leases over the past 2 years, most recently at $1.5 million for Q3 2023.

  • Quarterly results put Current Leases at $1.5 million for Q3 2023, up 122.27% from a year ago — trailing twelve months through Sep 2023 was $1.5 million (up 122.27% YoY), and the annual figure for FY2022 was $1.4 million, changed.
  • Current Leases for Q3 2023 was $1.5 million at Cullinan Therapeutics, down from $1.7 million in the prior quarter.
  • Over the last five years, Current Leases for CGEM hit a ceiling of $1.7 million in Q2 2023 and a floor of $519000.0 in Q1 2022.